Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

PowerMag™ DNA Isolation Kits from Cambio

Published: Monday, October 01, 2012
Last Updated: Monday, October 01, 2012
Bookmark and Share
Automated DNA extraction from complex soil and microbial samples.

PowerMag™ DNA isolation kits, available exclusively in the UK from Cambio, are the ultimate tool in isolating pure DNA from complex soil and microbial sample matrices.

Produced by MoBio, PowerMag™ kits are designed to work seamlessly with Kingfisher® or epMotion® automated processing systems for rapid and hands-free applications.

Users are provided with a complete solution for effectively and efficiently isolating high-quality, inhibitor-free DNA, suitable for use in downstream processes such as PCR and next generation sequencing, and are supported throughout by Cambio’s dedicated customer service.

Magnetic bead-based technologies are often the first choice for automated DNA isolation, but they are not without limitations.

When using traditional technologies to extract DNA from soil samples there is often surface binding to the beads. This allows for the adsorption of organic inhibitors.

The PowerMag™ Soil DNA isolation kit contains ClearMag™ technology, which inhibits this binding and facilitates the isolation of pure DNA.

When it comes to Microbial DNA extraction, the PowerMag™ Microbial DNA isolation kit includes SwiftMag™ technology.

By eliminating the need for chaotropic salts while binding nucleic acids to beads, even purer DNA can be captured in comparison to other methods.

All the PowerMag™ DNA isolation kits are optimized for use with the most difficult and complex samples, from soil and stool to food cultures and a variety of swabs.

The inclusion of MoBio’s Inhibitor Removal Technology® (IRT) removes PCR-inhibiting compounds such as lipids, phenolics and polysaccharides.

Users are left with high-quality, pure DNA that is ideal for use in downstream applications.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Gene Therapy for Metabolic Liver Diseases
Researchers have tested gene therapy in pigs from hereditary tyrosinemia type 1, with corrected liver cells being transplanted into the diseased liver.
Gene Terapy for Muscle Wasting Developed
New gene therapy could save millions of people suffering from muscle wasting disease.
Gene-Editing 'Toolbox' Targets Multiple Genes Simultaneously
Researchers have designed a system that modifies, or edits, multiple genes in a genome at once while minimising unintentional effects.
Discovering the First Farmers
Genetic analyses reveal a collection of highly distinct groups in the Near East and Europe at the dawn of agriculture.
Fighting Cancer Through Protein Pathways
Researchers have found a new drug target within a protein production pathway critical to regulating growth and proliferation of cells.
Mutations in DNA-Repair Genes Found in Advanced Prostate Cancers
New findings indicate that nearly 12% of male advanced prostate cancer sufferers have inherited mutation in DNA-repair genes.
Ice Bucket Challenge Instrumental in Gene Discovery
Donations from the ALS Ice Bucket Chellenge allowed for the largest-ever study of inherited ALS, which identified a new ALS gene.
Triple-Action Therapy Patch Shows Promise
Patch that delivers drug, gene, and light-based therapy to tumor sites shows promising results in mice.
Cancer Gene-Drug Combinations Ripe for Precision Medicine
The study aims to expand the number of cancer gene mutations that can be paired with a precision therapy.
Targeting BRAF Mutations in Thyroid Cancer
Treating metastatic thyroid cancer patients harboring a BRAF mutation with vemurafenib showed anti-tumor activity in a third of patients.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!